BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 24665980)

  • 41. Fetal PR Interval in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case-Control Study.
    Guerra M; Montaño I; Haye MT; Toro V; Maiz N
    Am J Perinatol; 2024 May; 41(S 01):e2964-e2969. PubMed ID: 37774745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereological assessment of placental morphology in intrahepatic cholestasis of pregnancy.
    Wikström Shemer E; Thorsell M; Östlund E; Blomgren B; Marschall HU
    Placenta; 2012 Nov; 33(11):914-8. PubMed ID: 23020907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011.
    ; Lee RH; Mara Greenberg ; Metz TD; Pettker CM
    Am J Obstet Gynecol; 2021 Feb; 224(2):B2-B9. PubMed ID: 33197417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Intrahepatic cholestasis of pregnancy: a disorder of increased fetal risks. Part I. Maternal condition].
    Jóźwik M; Jóźwik M; Bartnicki J; Jóźwik M
    Ginekol Pol; 2007 Apr; 78(4):312-6. PubMed ID: 17621995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
    Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
    Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Insights on Intrahepatic Cholestasis of Pregnancy.
    Floreani A; Gervasi MT
    Clin Liver Dis; 2016 Feb; 20(1):177-89. PubMed ID: 26593298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic and therapeutic profiles of serum bile acids in women with intrahepatic cholestasis of pregnancy-a pseudo-targeted metabolomics study.
    Cui Y; Xu B; Zhang X; He Y; Shao Y; Ding M
    Clin Chim Acta; 2018 Aug; 483():135-141. PubMed ID: 29709452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Chappell LC; Bell JL; Smith A; Linsell L; Juszczak E; Dixon PH; Chambers J; Hunter R; Dorling J; Williamson C; Thornton JG;
    Lancet; 2019 Sep; 394(10201):849-860. PubMed ID: 31378395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of ursodeoxycholic acid in patients with cholestasis of pregnancy].
    Palma J; Reyes H; Ribalta J; Iglesias J; González M; Hernández I; Alvarez C; Molina C; Danitz AM
    Rev Med Chil; 1991 Feb; 119(2):169-71. PubMed ID: 1824160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of obstetric cholestasis with polyunsaturated phosphatidylcholine and ursodeoxycholic acid].
    Marciniak B; Kimber-Trojnar Z; Leszczyńska-Gorzelak B; Patro-Małysza J; Trojnar M; Oleszczuk J
    Ginekol Pol; 2011 Jan; 82(1):26-31. PubMed ID: 21473053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial.
    Hague WM; Callaway L; Chambers J; Chappell L; Coat S; de Haan-Jebbink J; Dekker M; Dixon P; Dodd J; Fuller M; Gordijn S; Graham D; Heikinheimo O; Hennessy A; Kaaja R; Khong TY; Lampio L; Louise J; Makris A; Markus C; Marschall HU; Middleton P; Mol BW; Morris J; Newnham JP; Ovadia C; Peek M; Shand A; Stark M; Thornton J; Timonen S; Walker S; Warrilow D; Williamson C
    BMC Pregnancy Childbirth; 2021 Jan; 21(1):51. PubMed ID: 33435904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy.
    Geenes V; Chambers J; Khurana R; Shemer EW; Sia W; Mandair D; Elias E; Marschall HU; Hague W; Williamson C
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():59-63. PubMed ID: 25864112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
    Kowalska-Kańka A; Maciejewski T; Niemiec KT
    Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ursodeoxycholic acid improves pregnancy outcome in patients with intrahepatic cholestasis during pregnancy: A protocol for systematic review and meta-analysis.
    Wang Y; Peng X; Zhang Y; Yang Q; Xiao Y; Chen Y
    Medicine (Baltimore); 2021 Jan; 100(4):e23627. PubMed ID: 33530164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A placental phenotype for intrahepatic cholestasis of pregnancy.
    Geenes VL; Lim YH; Bowman N; Tailor H; Dixon PH; Chambers J; Brown L; Wyatt-Ashmead J; Bhakoo K; Williamson C
    Placenta; 2011 Dec; 32(12):1026-32. PubMed ID: 22015023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does mild intrahepatic cholestasis of pregnancy require an aggressive management? Evidence from a prospective observational study focused on adverse perinatal outcomes and pathological placental findings.
    Triunfo S; Tomaselli M; Ferraro MI; Latartara E; Sassara GM; Carrozza C
    J Matern Fetal Neonatal Med; 2022 Jan; 35(2):212-222. PubMed ID: 31957515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy.
    Roy A; Premkumar M; Mishra S; Mehtani R; Suri V; Aggarwal N; Singh S; Dhiman RK
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):571-576. PubMed ID: 33136720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine.
    Glantz A; Reilly SJ; Benthin L; Lammert F; Mattsson LA; Marschall HU
    Hepatology; 2008 Feb; 47(2):544-51. PubMed ID: 17968976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.